Search
for
Sort by
Research 271–300 of 1000+
- JAK Inhibitors for Treatment of Alopecia Areata
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Treatment of alopecia areata with squaric acid dibutylester
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases
- Gut microbiome, metabolome and alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Alopecia areata: current concepts
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo